Bridgeway Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$222K	Buy	185,000 +50,000	+37%	+$60.9K	﹤0.01%	1012
2025 Q4	$133K	Buy	135,000 +35,000	+35%	+$42K	﹤0.01%	1089
2025 Q3	$126K	Buy	100,000 +75,000	+300%	+$80.9K	﹤0.01%	1080
2025 Q2	$28K	Buy	+25,000	New	+$29.1K	﹤0.01%	1154
2018 Q2	–	Sell	-202,000	Closed	-$1.97M	–	1429
2018 Q1	$1.97M	Sell	202,000 -54,000	-21%	-$517K	0.02%	596
2017 Q4	$1.56M	Hold	256,000	–	–	0.02%	666
2017 Q3	$1.01M	Buy	256,000 +6,000	+2%	+$20.4K	0.01%	841
2017 Q2	$810K	Hold	250,000	–	–	0.01%	903
2017 Q1	$1.14M	Hold	250,000	–	–	0.01%	766
2016 Q4	$628K	Hold	250,000	–	–	0.01%	988
2016 Q3	$780K	Sell	250,000 -144,537	-37%	-$351K	0.01%	903
2016 Q2	$671K	Sell	394,537 -80,000	-17%	-$145K	0.01%	928
2016 Q1	$854K	Buy	474,537 +250,000	+111%	+$515K	0.01%	831
2015 Q4	$757K	Buy	224,537 +130,100	+138%	+$547K	0.01%	882
2015 Q3	$503K	Buy	94,437 +57,437	+155%	+$392K	0.01%	1022
2015 Q2	$239K	Buy	+37,000	New	+$221K	﹤0.01%	1315